IL-17C Inhibitors

Interleukin-17C (IL-17C) is a member of the IL-17 family, a unique cohort of cytokines implicated in the regulation of inflammatory responses and the orchestration of autoimmunity. Unlike its more studied counterparts, IL-17C exerts its effects primarily on epithelial cells, playing a crucial role in mucosal immunity and the body's defense against extracellular pathogens. It achieves this by promoting the expression of antimicrobial peptides, chemokines, and cytokines that facilitate the recruitment and activation of neutrophils and other immune cells to sites of infection. IL-17C's function is tightly linked to the maintenance of epithelial barrier integrity and the regulation of tissue repair processes. Its activity is modulated through its interaction with a distinct receptor complex, composed of the IL-17 receptor E (IL-17RE) and IL-17RA, highlighting a sophisticated mechanism of action that diverges from traditional cytokine-receptor engagements.

The inhibition of IL-17C involves targeting either the cytokine itself, its receptor complex, or the downstream signaling pathways it activates. This can be achieved through various biological mechanisms that directly or indirectly reduce the biological activity of IL-17C. One common method of inhibition includes the use of neutralizing antibodies that bind to IL-17C, preventing its interaction with the IL-17RE/RA receptor complex, thereby blocking its pro-inflammatory signaling cascade. Another approach targets the receptor complex itself, disrupting the IL-17C-mediated signaling pathway. Additionally, small molecule inhibitors can interfere with the intracellular signaling pathways activated by IL-17C, such as those involving NF-κB and MAPKs, which are critical for the transcription of target genes involved in inflammation and immune responses. These inhibitory mechanisms collectively contribute to the reduction of IL-17C-mediated effects on epithelial cells, potentially attenuating excessive inflammatory responses without directly naming specific inhibitors, focusing instead on the broad strategies employed to mitigate the cytokine's activity within the immune system.